WHO ICTRP trial

predicting efficiancy of ropivacaine with fentanyl and magnesium sulphate…

CTRI/2022/07/044420 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2022/07/044420
Public title predicting efficiancy of ropivacaine with fentanyl and magnesium sulphate through intravenous regional anaesthesia for all hand surgeries
Scientific title Comparison of Magnesium Sulphate and Fentanyl as an Adjuvant to Ropivacaine in Intravenous Regional Anaesthesia for Upper Extremity Surgeries-A Prospective Randomised Double Blind Clinical Study
Primary sponsor Krishna Institute of medical sciences Deemed To Be University
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: S698- Other specified injuries of wrist,hand and finger(s)
Interventions Intervention1: fentanyl: group RF: patients receiving fentanyl 50mcgs along with 0.2%ropivacaine as Intra venous regional anaesthesia to assess sensory and motor blockade and time to first analgesia Control Intervention1: magnesium…
Registration date Jul 28, 2022
Target size 60
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations